Market Research Logo

Asia Pacific Exosome Diagnostic And Therapeutic Market Forecast 2019-2027

Asia Pacific Exosome Diagnostic And Therapeutic Market Forecast 2019-2027

KEY FINDINGS

The global exosome diagnostic and therapeutic market by the Asia Pacific region is estimated to grow from $XX million in 2018 to $XX million by 2027, at a CAGR of 28.19% between 2019 and 2027.

MARKET INSIGHTS

The market for exosome diagnostic and therapeutic in APAC is mainly driven by the increase in the pervasiveness of cancer, rising government and non-government initiatives and the advancement in technology. In 2018, the diagnostic application segment accounted for the largest share of approx. XX% of the overall exosome diagnostic and therapeutic market.

Japan, China, India, Australia, South Korea, and other countries together forming the Rest of Asia Pacific regional segment are the major economies shaping up the market trends of the regional market. Asia-Pacific is a solidly packed region, with China being the most populated country. So, the country’s growth, which is supplemented by the substantially larger base of cancer patients, will increase the demand for exosome diagnostic and therapeutic products.

COMPETITIVE INSIGHTS

Hitachi Chemical Diagnostics, Inc., Qiagen N.V., System Biosciences (SBI), Malvern Instruments Ltd., Codiak BioSciences, Capricor Therapeutics, Inc., Nanosomix Inc., Sistemic Ltd., MBL International Corporation, BioCat GmbH, Thermo Fisher Scientific Inc., EVOX Therapeutics Ltd., Exosome Diagnostics Inc., HansaBioMed Life Sciences Ltd. (acquired by Lonza), and Aethlon Medical, Inc. are some of the contending market players operating that are mentioned in the report.


1. Research Scope
1.1. Study Goals
1.2. Scope Of The Market Study
1.3. Who Will Find This Report Useful?
1.4. Study And Forecasting Years
2. Research Methodology
2.1. Sources Of Data
2.1.1. Secondary Data
2.1.2. Primary Data
2.2. Top-down Approach
2.3. Bottom-up Approach
2.4. Data Triangulation
3. Executive Summary
3.1. Market Summary
3.2. Key Findings
3.2.1. Diagnostic Is The Majorly Used Application
3.2.2. Software Segment Is Anticipated To Grow At A Significant Rate
3.2.3. Cancer Institutes Hold The Largest Market Share In Terms Of End-user
4. Market Dynamics
4.1. Market Scope & Definition
4.2. Market Drivers
4.2.1. Increase In Pervasiveness Of Cancer
4.2.2. Rising Government And Non-government Initiatives
4.2.3. Advancement In Technology
4.3. Market Restraints
4.3.1. Challenges Faced In The Usage Of Exosome
4.3.2. Stringent Regulation
4.4. Market Opportunities
4.4.1. Lucrative Growth Opportunities In The Emerging Economies
4.4.2. Increase In Adoption Of Innovative And Advanced Exosome Diagnostic And Therapeutic Procedures
4.5. Market Challenges
4.5.1. Low Awareness In The Developing Countries
5. Market By Application
5.1. Diagnostic
5.2. Therapeutic
6. Market By Product
6.1. Instrument
6.2. Reagent
6.3. Software
7. Market By End-user
7.1. Cancer Institute
7.2. Hospital
7.3. Diagnostic Center
7.4. Other End-user
8. Key Analytics
8.1. Porter’s Five Forces Model
8.1.1. Threat Of New Entrants
8.1.2. Threat Of Substitute
8.1.3. Bargaining Power Of Buyers
8.1.4. Bargaining Power Of Suppliers
8.1.5. Threat Of Competitive Rivalry
8.2. Exosome Etymology
8.3. Patent Analysis
8.4. Components Of Exosome
8.5. Opportunity Matrix
9. Geographical Analysis
9.1. Asia Pacific
9.1.1. Japan
9.1.2. China
9.1.3. India
9.1.4. Australia
9.1.5. South Korea
9.1.6. Rest Of Asia Pacific
10. Competitive Landscape
10.1. Company Profiles
10.1.1. Aethlon Medical, Inc.
10.1.2. Biocat Gmbh
10.1.3. Capricor Therapeutics, Inc.
10.1.4. Codiak Biosciences
10.1.5. Evox Therapeutics Ltd.
10.1.6. Exosome Diagnostics Inc.
10.1.7. Hansabiomed Life Sciences Ltd. (Acquired By Lonza)
10.1.8. Hitachi Chemical Diagnostics, Inc.
10.1.9. Malvern Instruments Ltd.
10.1.10. Mbl International Corporation
10.1.11. Nanosomix Inc.
10.1.12. Sistemic Ltd.
10.1.13. System Biosciences (Sbi)
10.1.14. Thermo Fisher Scientific Inc.
10.1.15. Qiagen N.V.
Table List
Table 1 Nomenclature Of Exosome Particles
Table 2 Asia Pacific Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Table 3 Asia Pacific Exosome Diagnostic And Therapeutic Market By Application 2019-2027 ($ Million)
Table 4 Asia Pacific Diagnostic Market 2019-2027 ($ Million)
Table 5 Asia Pacific Therapeutic Market 2019-2027 ($ Million)
Table 6 Asia Pacific Exosome Diagnostic And Therapeutic Market By Product 2019-2027 ($ Million)
Table 7 Asia Pacific Instrument Market 2019-2027 ($ Million)
Table 8 Commercial Kits And Reagents Examples For The Isolation Of Exosome
Table 9 Asia Pacific Reagent Market 2019-2027 ($ Million)
Table 10 Asia Pacific Software Market 2019-2027 ($ Million)
Table 11 Asia Pacific Exosome Diagnostic And Therapeutic Market By End-user 2019-2027 ($ Million)
Table 12 Asia Pacific Cancer Institute Market 2019-2027 ($ Million)
Table 13 Asia Pacific Hospital Market 2019-2027 ($ Million)
Table 14 Exosome Associated Protein In Clinical Diagnostics Usage
Table 15 Asia Pacific Diagnostic Center Market 2019-2027 ($ Million)
Table 16 Asia Pacific Other End-user Market 2019-2027 ($ Million)
Table 17 Type Of Proteins Found In Exosomes
Table 18 Asia Pacific Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Table 19 Asia Pacific Exosome Diagnostic And Therapeutic Market By Country 2019-2027 ($ Million)
Table 20 Estimated Most Common Cancers Diagnosed In Australia 2017
Figures List
Figure 1 Asia Pacific Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 2 Asia Pacific Exosome Diagnostic And Therapeutic Market Share By Application 2018 & 2027 (%)
Figure 3 Asia Pacific Exosome Diagnostic And Therapeutic Market By Diagnostic 2019-2027 ($ Million)
Figure 4 Asia Pacific Exosome Diagnostic And Therapeutic Market By Therapeutic 2019-2027 ($ Million)
Figure 5 Asia Pacific Exosome Diagnostic And Therapeutic Market Share By Product 2018 & 2027 (%)
Figure 6 Asia Pacific Exosome Diagnostic And Therapeutic Market By Instrument 2019-2027 ($ Million)
Figure 7 Asia Pacific Exosome Diagnostic And Therapeutic Market By Reagent 2019-2027 ($ Million)
Figure 8 Asia Pacific Exosome Diagnostic And Therapeutic Market By Software 2019-2027 ($ Million)
Figure 9 Asia Pacific Exosome Diagnostic And Therapeutic Market Share By End-user 2018 & 2027 (%)
Figure 10 Asia Pacific Exosome Diagnostic And Therapeutic Market By Cancer Institute 2019-2027 ($ Million)
Figure 11 Asia Pacific Exosome Diagnostic And Therapeutic Market By Hospital 2019-2027 ($ Million)
Figure 12 Asia Pacific Exosome Diagnostic And Therapeutic Market By Diagnostic Center 2019-2027 ($ Million)
Figure 13 Asia Pacific Exosome Diagnostic And Therapeutic Market By Other End-user 2019-2027 ($ Million)
Figure 14 Porter’s Five Force Model
Figure 15 Number Of Papers Published On Exosome 2003-2017
Figure 16 Japan Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 17 China Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 18 India Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 19 Australia Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 20 South Korea Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)
Figure 21 Rest Of Asia Pacific Exosome Diagnostic And Therapeutic Market 2019-2027 ($ Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook